Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer: A hoosier oncology group study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer: A hoosier oncology group study

Published:1992-11-15 Issue:10 Volume:70 Page:2488-2492
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Saxman Scott,Ansari Rafat,Drasga Ray,Miller Michael,Wheeler Ben,McClean John,Einhorn Lawrence

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. Carcinoma of the Prostate

2. Prostatic Carcinoma

3. Chemotherapy of Advanced Prostatic Carcinoma with Cyclophosphamide or 5-Fluorouracil: Results of First National Randomized Study

4. The Chemotherapy of Prostatic Adenocarcinoma

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model;Oncotarget;2017-10-20

2. One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling;International Journal of Molecular Sciences;2016-07-27

3. Pemetrexed as second-line chemotherapy for castration-resistant prostate cancer after docetaxel failure: Results from a phase II study;Urologic Oncology: Seminars and Original Investigations;2013-02

4. Prolonged Remission of Fulminant Castrate-Resistant Prostate Cancer: A Case Report;Clinical Genitourinary Cancer;2011-12

5. Second-line therapy for castrate-resistant prostate cancer: A literature review;Asia-Pacific Journal of Clinical Oncology;2011-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP